Variants of SARS-CoV-2 was a Natural sciences good articles nominee, but did not meet the good article criteria at the time. There may be suggestions below for improving the article. Once these issues have been addressed, the article can be renominated. Editors may also seek a reassessment of the decision if they believe there was a mistake.
Article milestones Date Process Result March 20, 2022 Good article nominee Not listed

This article is rated C-class on Wikipedia's content assessment scale. It is of interest to multiple WikiProjects.

Molecular Biology: Genetics Low‑importance This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles Low This article has been rated as Low-importance on the importance scale. This article is supported by the Genetics task force (assessed as Low-importance). COVID-19 High‑importance This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles High This article has been rated as High-importance on the project's importance scale. Medicine: Emergency / Society / Pulmonology Low‑importance This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles Low This article has been rated as Low-importance on the project's importance scale. This article is supported by the Emergency medicine and EMS task force (assessed as Mid-importance). This article is supported by the Society and Medicine task force (assessed as Mid-importance). This article is supported by the Pulmonology task force (assessed as High-importance). Viruses Mid‑importance This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles Mid This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Variants of SARS-CoV-2. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

Text and/or other creative content from this version of Severe acute respiratory syndrome coronavirus 2#Strains and variants was copied or moved into Severe acute respiratory syndrome coronavirus 2 variants with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

Text and/or other creative content from this version of 501.V2 Variant was copied or moved into Severe acute respiratory syndrome coronavirus 2 variants with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

Text and/or other creative content from this version of Cluster 5 was copied or moved into Severe acute respiratory syndrome coronavirus 2 variants with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

Text and/or other creative content from this version of VOC-202012/01 was copied or moved into Severe acute respiratory syndrome coronavirus 2 variants with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

This is the talk page for discussing improvements to the Variants of SARS-CoV-2 article. This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic. New to Wikipedia? Welcome! Learn to edit; get help. Assume good faith Be polite and avoid personal attacks Be welcoming to newcomers Seek dispute resolution if needed Article policies Neutral point of view No original research Verifiability

Find medical sources:  Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1Auto-archiving period: 60 days

The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

WikiProject COVID-19 consensus WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page. General Superseded by TfD October 2020 and later practice - consult regular {{ Current}} guidance. Refrain from using Worldometer (worldometers.info) as a source due to common errors being observed as noted on the Case Count Task Force common errors page. ( April 2020, April 2020) For infoboxes on the main articles of countries, use Wuhan, Hubei, China for the origin parameter. ( March 2020) "Social distancing" is generally preferred over "physical distancing". ( April 2020, May 2020) Page title COVID-19 (full caps) is preferable in the body of all articles, and in the title of all articles/category pages/etc.( RM April 2020, including the main article itself, RM March 2021). SARS-CoV-2 (exact capitalisation and punctuation) is the common name of the virus and should be used for the main article's title, as well as in the body of all articles, and in the title of all other articles/category pages/etc. ( June 2022, overturning April 2020) Map There is no consensus about which color schemes to use, but they should be consistent within articles as much as possible. There is agreement that there should be six levels of shading, plus gray   for areas with no instances or no data. ( May 2020) There is no consensus about whether the legend, the date, and other elements should appear in the map image itself. ( May 2020) For map legends, ranges should use fixed round numbers (as opposed to updating dynamically). There is no consensus on what base population to use for per capita maps. ( May 2020) To ensure you are viewing the current list, you may wish to purge this page.

Daily pageviews of this article A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org

Section sizes Section size for Variants of SARS-CoV-2 (68 sections) Section name Byte count Section total (Top) 2,901 2,901 Overview 27,498 27,498 Nomenclature 10,995 18,722 Lineages and clades 5,651 5,651 Classification of variants 2,076 2,076 Reference sequence 5,327 5,327 Notability criteria 3,215 3,215 Variants of concern (WHO) 821 14,689 Omicron 51 13,868 Lineage B.1.1.529 4,022 4,022 BA. sublineages 2,018 2,018 Further sublineages emerging in 2022 1,338 1,338 Further sublineages emerging in 2023: EG.5 "Eris", BA.2.86, and JN.1 "Pirola" 5,344 5,344 Further sublineages emerging in 2024: KP.1.1, KP.2 ("FLiRT") 1,095 1,095 Variant of concern lineages under monitoring (WHO) 2,078 2,078 Variants of interest (WHO) 1,945 1,945 Variants under monitoring (WHO) 568 568 Previously circulating and formerly monitored variants (WHO) 474 76,256 Previously circulating variants of concern (VOC) 299 46,531 Alpha (lineage B.1.1.7) 10,889 14,229 B.1.1.7 with E484K 3,340 3,340 Beta (lineage B.1.351) 6,343 6,343 Gamma (lineage P.1) 13,230 13,230 Delta (lineage B.1.617.2) 12,430 12,430 Previously circulating variants of interest (VOI) 1,055 27,621 Epsilon (lineages B.1.429, B.1.427, CAL.20C) 10,334 10,334 Zeta (lineage P.2) 620 620 Eta (lineage B.1.525) 4,359 4,359 Theta (lineage P.3) 4,585 4,585 Iota (lineage B.1.526) 924 924 Kappa (lineage B.1.617.1) 2,160 2,160 Lambda (lineage C.37) 2,114 2,114 Mu (lineage B.1.621) 1,470 1,470 Formerly monitored variants (WHO) 1,630 1,630 Other notable variants 15,175 15,175 Notable missense mutations 109 38,550 del 69-70 708 708 RSYLTPGD246-253N 2,409 2,409 N440K 1,929 1,929 G446V 1,168 1,168 L452R 780 780 Y453F 765 765 S477G/N 2,469 2,469 E484Q 1,278 1,278 E484K 5,806 5,806 F490S 1,443 1,443 N501Y 2,624 2,624 N501S 1,687 1,687 D614G 5,847 5,847 Q677P/H 2,209 2,209 P681H 2,062 2,062 P681R 505 505 A701V 4,752 4,752 Recombinant variants 1,519 1,519 Differential vaccine effectiveness 2,299 2,475 Immune evasion by variants 89 176 Vaccine adjustments 87 87 Data and methods 2,319 8,960 New variant detection and assessment 3,960 3,960 Testing 2,681 2,681 Incubation theory for multiple mutated variants 2,023 2,023 Cross-species transmission 2,089 6,390 Cluster 5 4,301 4,301 See also 361 361 Notes 517 517 References 4,173 4,173 Further reading 1,026 1,026 External links 440 440 Total 234,808 234,808

Tip: Anchors are case-sensitive in most browsers. This article links to one or more target anchors that no longer exist. [[COVID-19 pandemic in the United Kingdom#New cases by day reported|COVID-19 infection in United Kingdom]] The anchor (#New cases by day reported) has been deleted. Please help fix the broken anchors. You can remove this template after fixing the problems. | Reporting errors

In the main section of the article, citation 4 is listed as "failed verification" because its most recent listed accessed date is 2022 and the sentence citing the page lists a date in 2024. This WHO page ( link) is updated frequently. At time of writing, the apparent most recent update was 15 April 2024, when an updated risk evaluation for JN.1 was added, and the page itself claims to be up to date as of 3 May 2024. What is the appropriate way to cite a single URL which updates frequently? 184.62.88.78 ( talk) 20:24, 9 May 2024 (UTC) reply

will look-- Ozzie10aaaa ( talk) 22:44, 9 May 2024 (UTC) reply

I'm somewhat reluctant to start a new section, but my source mentions this variant and doesn't say it began in 2023. If it didn't start in 2023, it must have started in 2024.— Vchimpanzee • talk • contributions • 19:06, 14 May 2024 (UTC) reply

Retraction watch has flagged an erratum re the Tang paper. The authors write: "We now recognize that within the context of our study the term “aggressive” is misleading and should be replaced by a more precise term “a higher frequency”. In short, while we have shown that the two lineages naturally co-exist, we provided no evidence supporting any epidemiological conclusion regarding the virulence or pathogenicity of SARS-CoV-2..." My impression is that the elements of the retraction don't affect the words currently used in this article. Could this be checked by an expert? Yadsalohcin ( talk) 08:44, 14 June 2024 (UTC) reply

The sentence in lead section "As of June 2024, only Omicron is designated as a circulating variant of concern by the World Health Organization." is incorrect. The website itself (updated on 5 June 2024) used as a source for this sentence doesn't list any circulating VoCs.

This WHO's statement from 16 March 2023 states "With these changes factored in, Alpha, Beta, Gamma, Delta as well as the Omicron parent lineage (B.1.1.529) are considered previously circulating VOCs."

Omicron's sublineages and their descendants were given separate labels such as VOI and VUM. KapSoule ( talk) 11:33, 16 June 2024 (UTC) reply